交易 Compass Therapeutics, Inc. - CMPX 差价合约
Compass Therapeutics Inc. (NASDAQ: CMPX) is a clinical-stage biotechnology company developing next-generation antibody therapeutics for cancer and autoimmune diseases. Its pipeline includes immune checkpoint inhibitors and T-cell engagers with enhanced potency and selectivity. Compass emphasizes modular design and multispecific formats to overcome limitations of current biologics. It provides investors early exposure to high-potential oncology innovation and differentiated biologic platforms.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


